Smartphones to Improve Rivaroxaban ADHEREnce in Atrial Fibrillation
A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 139 participants.
Also called NCT02996435
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose other
- Phase
- Phase 4
- Enrolled
- 139 participants
- Registry
-
NCT02996435
-
- Other papers using this trial's data
- Efficacy of a centralized, blended electronic, and human intervention to improve direct oral anticoagulant adherence: Smartphones to improve rivaroxaban ADHEREnce in atrial fibrillation (SmartADHERE) a randomized clinical trial
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- United States
- Registry status
- Completed
Technical summary
Registry record NCT02996435. Randomized; no masking; primary purpose other. Start 2016-12-21 (actual); primary completion 2018-03-22 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Smartphones to Improve Rivaroxaban ADHEREnce in Atrial Fibrillation
- Condition
- Atrial Fibrillation
- Intervention (Behavioral)
- Mobile Application Intervention
- Intervention (Other)
- No Intervention
- Lead sponsor
- Janssen Scientific Affairs, LLC
Record details
- Record id
cardio:ct-nct02996435- Content hash
66cb6064d1f08ddceba7b3c412130b35883e95fca606f1c066d1c3617ba56fa0